MI:RNA is developing a noninvasive, blood-based diagnostic that pairs a microRNA expression panel with advanced modeling to detect osteoarthritis in dogs earlier, supported by funding from Scottish Enterprise amid estimates that 10 million UK and 14 million US dogs are affected. Read On…